MedTrace Logo

The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia Major

NCT04260516 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-02-07

No results posted yet for this study

Summary

The effect of N-acetylcysteine as antioxidant and its effect on pretransfusion hemoglobin and iron overload in patients with thalassemia were compared to patients who didn't receive n-acetylcysteine after 3 months of study duration

Conditions

  • Thalassemia Major

Interventions

DRUG

N-acetyl cysteine

Mucolytic and antioxidant drug

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Heba M Ahmed · Beni-Suef University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-03
Primary Completion
2019-12-03
Completion
2019-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04260516 on ClinicalTrials.gov